Results 181 to 190 of about 113,709 (339)

Cadmium-contaminated jambu: carcinogenic and non-carcinogenic risks to human health

open access: bronze, 2023
Washington Aleksander Savaris dos Santos   +3 more
openalex   +2 more sources

Navigating the Genetic Risk of Chemotherapy‐Induced Hearing Loss in the Stria Vascularis

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Cisplatin is a chemotherapy drug that causes permanent hearing loss by damaging a critical tissue lining the inner ear, called the stria vascularis (SV). Currently, the molecular mechanisms of SV damage are largely unknown and the incidence of ototoxicity in patients cannot be reliably predicted.
Tara Lazetic   +4 more
wiley   +1 more source

PharmVar GeneFocus: NAT2—Genetic Variation and Updated Nomenclature

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
The Pharmacogene Variation Consortium (PharmVar) provides nomenclature for the highly polymorphic human N‐acetyltransferase 2 (NAT2) gene. NAT2 metabolizes several clinically used drugs including isoniazid, hydralazine, amifampridine, procainamide, and sulfonamides such as dapsone, and also some highly carcinogenic arylamines.
Georgia Papanikolaou   +14 more
wiley   +1 more source

Carcinogenicity of vinyl acetate: evidence from multiple data streams. [PDF]

open access: yesEnviron Health
Li K   +9 more
europepmc   +1 more source

Carcinogenic and Non-carcinogenic Health Risk Assessment of Heavy Metals in Njaba River, Imo State, Nigeria

open access: diamond, 2021
Victor Chukwuemeka Eze   +2 more
openalex   +1 more source

Do Firms Hoard Cash Under Environmental Pressure? Insights From GHG Emissions and Greenwashing Activities

open access: yesCorporate Social Responsibility and Environmental Management, EarlyView.
ABSTRACT Environmental accountability has become a global priority, with governments implementing policies like the Kyoto Protocol and the Paris Agreement. However, many firms continue to operate outside environmentally ethical standards, facing potential regulatory, financial, and reputational risks.
Ones Amri   +3 more
wiley   +1 more source

A new database contains 520 studies investigating the carcinogenicity data of 238 pharmaceuticals across 14 ATC classifications

open access: yesFrontiers in Toxicology
Panagiotis G. Karamertzanis   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy